Cellebrite Di Ltd. ( (CLBT) ) has released its Q3 earnings. Here is a breakdown of the information Cellebrite Di Ltd. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cellebrite DI Ltd. is a global leader in digital investigative solutions, serving both public and private sectors with advanced technology for digital forensics and intelligence gathering. The company recently reported its third-quarter 2025 financial results, showcasing strong growth in revenue and annual recurring revenue (ARR), alongside a solid net income performance.
In the third quarter of 2025, Cellebrite reported a revenue increase of 18% year-over-year, reaching $126 million, while ARR grew by 19% to $439.8 million. The company’s net income stood at $20.2 million, with a non-GAAP net income of $36.9 million and an adjusted EBITDA of $37.7 million, reflecting a 29.9% adjusted EBITDA margin. These results highlight the company’s robust financial health and operational efficiency.
Key highlights from the quarter include a significant expansion in the U.S. Federal business sector, bolstered by partnerships and the anticipated completion of the Corellium acquisition. Additionally, Cellebrite launched its Autumn 2025 Release, enhancing its Digital Investigation Platform with new AI-powered capabilities and integrations, further strengthening its product portfolio.
Looking ahead, Cellebrite’s management remains optimistic about future growth prospects, particularly in the U.S. Federal sector and through continued product innovation and strategic acquisitions. The company anticipates continued revenue growth and profitability, with expectations for a free cash flow margin of approximately 30% for the full year 2025.